Ally Bridge Group - ABG
Ally Bridge Group is a private equity firm specializing in alternative asset classes such as venture capital, growth capital, PIPEs, buyout and hedge fund investments.
The firm invests in healthcare, life sciences, disruptive technology platforms in both medical devices and biopharmaceuticals with a focus on immuno-oncology and specialty pharma.
It invests globally with a focus on companies based in United States, Hong Kong, and China.
Ally Bridge Group was founded in 2013 and is based in Central, Hong Kong with additional offices in China and United States.